Biotech Values

[BTH]

Why do you keep making these kinds of statements?

Why?

Harvey Berger's words (why even say it, if you didn't think it was a possibility???? When the CEO of a public biotech says something like below, he's giving the impression to outside investors that he 'knows something' that others don't. You can spin it any way you want...it's all semantics and wording. Your intrepretation versus mine. And, obviously, investors were hoping for an NDA filing)

"Based on the current status of enrollment and disease progression events in the Phase 3 SUCCEED trial of ridaforolimus, as well as the statistical power and design of the trial, the Company believes that there is a reasonable possibility that the available clinical data at the time of the second interim analysis of efficacy by the independent Data Safety Monitoring Board would be sufficient to demonstrate a statistically significant difference in the primary endpoint of the trial, progression-free survival, when comparing the ridaforolimus and placebo treated patients. The Company believes that such an outcome would enable it to submit an NDA to the FDA in mid-2010 and allow for the possibility of FDA approval of ridaforolimus by the end of 2010 or early 2011."